Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B
Authors:
- Elisabete ArreseEAElisabete Arrese
- Miren BasarasMBMiren Basaras
- Sonia BlancoSBSonia Blanco
- Pablo RuizPRPablo Ruiz
- Ramόn CisternaRCRamόn Cisterna
Open Access
- 1 October 2011
- journal article
- Published by Elsevier in Annals of Hepatology
- Vol. 10 (4) , 434-440
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis BDigestive Diseases and Sciences, 2010
- Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone†Hepatology, 2009
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #Hepatology, 2009
- Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analoguesClinical Therapeutics, 2009
- Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized ApproachGastroenterology, 2008
- Evolution of Primary and Compensatory Lamivudine Resistance Mutations in Chronic Hepatitis B Virus-Infected Patients during Long-Term Lamivudine Treatment, Assessed by a Line Probe AssayJournal of Clinical Microbiology, 2007
- Antiviral drug-resistant HBVHepatology, 2007
- Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions PresentAntimicrobial Agents and Chemotherapy, 2007
- Detection of rtN236T and rtA181V/T Mutations Associated with Resistance to Adefovir Dipivoxil in Samples from Patients with Chronic Hepatitis B Virus Infection by the INNO-LiPA HBV DR Line Probe Assay (Version 2)Journal of Clinical Microbiology, 2006
- Antiviral Drug Resistance: Clinical Consequences and Molecular AspectsSeminars in Liver Disease, 2006